PECA Labs is a Carnegie Mellon and University of Pittsburgh Medical Center spin-off organized around provision of medical devices to orphan populations. With initial focus on the pediatric cardiovascular system, the firm's first product, the MASA Valve, is a novel synthetic heart valve for a rare pediatric cardiac reconstructive procedure. The MASA Valve has already received Humanitarian Use Device (HUD) designation from the FDA, and 70 human implantations of the intra-operatively constructed version have shown improved freedom from re-operation compared to any currently available option. PECA Labs® is currently developing the first: Synthetic Valved Conduit for Right Ventricular Outflow Tract Reconstruction (RVOTR) and the first Controllably-Expandable Vascular Graf The firm now has a suite of disruptive products in development, intended to provide significantly improved outcomes for children born with rare congenital heart defects.
